AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics
Hudson Pacific Properties' reported fundamentals have deteriorated sharply, with revenue falling from $218.0M in 2024Q2 to $184.1M in 2026Q3 and FFO swinging to negative $136.4M in the latest quarter, which suggests the dividend is no longer covered by recurring earnings.
Price trend, volume and key moving averages
Trailing total returns as of 11/18/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q4 2026Latest Nov 5, 2026 | -$3.38-363.0% vs -$0.73 | $181M-0.4% vs $182M |
Q3 2026 Aug 5, 2026 | -$1.62-124.0% vs -$0.72 | $188M+3.6% vs $182M |
Q2 2026 May 7, 2026 | $0.82+355.6% vs $0.18 | $182M+3.8% vs $175M |
Q1 2026 Feb 26, 2026 | $4.31+2055.0% vs $0.20 | $256M+36.8% vs $187M |
AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics
Hudson Pacific Properties NYSE: HPP raised its full-year earnings outlook after third-quarter office occupancy improved and its studio business generated higher income, although asset dispositions weighed on revenue and impairment charges widened its net loss.
Hudson Pacific Properties, Inc. (HPP) Q3 2026 Earnings Call Transcript
Hudson Pacific Properties (HPP) came out with quarterly funds from operations (FFO) of $0.28 per share, beating the Zacks Consensus Estimate of $0.25 per share. This compares to FFO of $0.28 per share a year ago.
Benchmark HPP against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for Hudson Pacific Properties, Inc. (HPP)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $9.12 | $494.69M | -0.92 | -1.3% | -79.24% | -21.13% | 0.09% | |
| $9.66 | $1.62B | -77.78 | 1.77% | -2.04% | -0.6% | 7.87% | |
| $35.78 | $4.16B | 146.82 | -2.02% | 2.63% | 0.52% | 6.06% | |
| $9.90 | $1.24B | -14.01 | -0.93% | -15.18% | -5.98% | 2.51% | |
| $30.54 | $3.37B | 18.29 | -2.39% | 22.01% | 7.31% | 6.42% | |
| $62.78 | $10.01B | 18.85 | 2.19% | 15% | 6.89% | 6.45% |
Hudson Pacific Properties, Inc. (HPP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
Hudson Pacific Properties, Inc. (HPP) SEC filings — annual & quarterly reports (10-K, 10-Q)
Nov 5, 2026·SEC
Aug 5, 2026·SEC
Jun 22, 2026·SEC
Get notified when HPP posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Hudson Pacific Properties, Inc. (HPP) stock FAQ — growth, dividends, profitability & financials explained
Hudson Pacific Properties, Inc. (HPP) reported $810.2M in revenue over the trailing twelve months. Revenue was $831.1M in fiscal year 2025. That is 11836% more than the $7.0M of fiscal year 2007.
Hudson Pacific Properties, Inc. (HPP) grew revenue by 3.2% over the trailing twelve months, compared with the twelve months before.
No. Hudson Pacific Properties, Inc. (HPP) reported a net loss of $642.0M over the trailing twelve months.
Hudson Pacific Properties, Inc. (HPP) does not currently pay a meaningful dividend.
Hudson Pacific Properties, Inc. (HPP) had a return on equity (ROE) of -21.1% over the trailing twelve months. A negative ROE means the company lost money over the period.
Hudson Pacific Properties, Inc. (HPP) generated Funds From Operations (FFO) of $-305.5M in the trailing twelve months. FFO is the primary profitability metric for REITs.